Vascular Endothelial Growth Factor A
"Vascular Endothelial Growth Factor A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.
Descriptor ID |
D042461
|
MeSH Number(s) |
D12.644.276.100.800.200 D12.776.467.100.800.200 D23.529.100.800.200
|
Concept/Terms |
Vascular Endothelial Growth Factor A- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factor-A
- VEGF-A
- Vasculotropin
- VEGF
- Vascular Endothelial Growth Factor
- Vascular Permeability Factor
- Permeability Factor, Vascular
|
Below are MeSH descriptors whose meaning is more general than "Vascular Endothelial Growth Factor A".
Below are MeSH descriptors whose meaning is more specific than "Vascular Endothelial Growth Factor A".
This graph shows the total number of publications written about "Vascular Endothelial Growth Factor A" by people in this website by year, and whether "Vascular Endothelial Growth Factor A" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 2 | 2 |
1998 | 0 | 1 | 1 |
2002 | 0 | 2 | 2 |
2003 | 0 | 1 | 1 |
2004 | 1 | 1 | 2 |
2005 | 3 | 3 | 6 |
2006 | 0 | 2 | 2 |
2007 | 0 | 6 | 6 |
2008 | 0 | 3 | 3 |
2009 | 9 | 4 | 13 |
2010 | 5 | 8 | 13 |
2011 | 3 | 3 | 6 |
2012 | 4 | 6 | 10 |
2013 | 1 | 7 | 8 |
2014 | 1 | 6 | 7 |
2015 | 2 | 3 | 5 |
2016 | 0 | 4 | 4 |
2017 | 4 | 4 | 8 |
2018 | 3 | 1 | 4 |
2019 | 2 | 2 | 4 |
2021 | 3 | 2 | 5 |
2022 | 0 | 4 | 4 |
2023 | 1 | 2 | 3 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vascular Endothelial Growth Factor A" by people in Profiles.
-
Current trends in the management of corneal neovascularization. Curr Opin Ophthalmol. 2024 Jul 01; 35(4):329-342.
-
Phylogenetic and transcriptomic characterization of insulin and growth factor receptor tyrosine kinases in crustaceans. Front Endocrinol (Lausanne). 2024; 15:1379231.
-
PRMT5 is a therapeutic target in choroidal neovascularization. Sci Rep. 2023 01 31; 13(1):1747.
-
Osteopontin contributes to virus resistance associated with type I IFN expression, activation of downstream ifn-inducible effector genes, and CCR2+CD115+CD206+ macrophage infiltration following ocular HSV-1 infection of mice. Front Immunol. 2022; 13:1028341.
-
Critical Role of VEGF as a Direct Regulator of Photoreceptor Function. Adv Exp Med Biol. 2023; 1415:487-491.
-
Platelet-Rich Plasma Injections: Pharmacological and Clinical Considerations in Pain Management. Curr Pain Headache Rep. 2022 Oct; 26(10):741-749.
-
Antibody deposition on vascular endothelial cells contributes to localized inflammation in salivary glands. J Oral Pathol Med. 2022 Aug; 51(7):674-677.
-
Bone Mass Accrual in First Six Months of Life: Impact of Maternal Diabetes, Infant Adiposity, and Cord Blood Adipokines. Calcif Tissue Int. 2022 09; 111(3):248-255.
-
Biology and Treatment of Meningiomas: A Reappraisal. Hematol Oncol Clin North Am. 2022 02; 36(1):133-146.
-
Novel Regulators of Retina Neovascularization: A Proteomics Approach. J Proteome Res. 2022 01 07; 21(1):101-117.